Results 41 to 50 of about 116,083 (186)
Background Tropomyosin receptor kinases (TrkA, TrkB, TrkC) are a family of tyrosine kinases primarily expressed in neuronal cells of the brain. Identification of oncogenic alterations in Trk expression as a driver in multiple tumor types has increased ...
Melinda Wuest +7 more
doaj +1 more source
New, potent, small molecule agonists of tyrosine kinase receptors attenuate dry eye disease
Nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophin3 (NT-3) bind to tyrosine kinase (Trk) receptors, TrkA, TrkB, and TrkC, respectively. This study investigated the efficacy of novel molecule agonists of Trk receptors in
Zhiyuan Yu +5 more
doaj +1 more source
Two-dimensional effective action for matter fields coupled to the dilaton [PDF]
We revise the calculation of the one-loop effective action for scalar and spinor fields coupled to the dilaton in two dimensions. Applying the method of covariant perturbation theory for the heat kernel we derive the effective action in an explicitly ...
A. G. Mirzabekian +38 more
core +2 more sources
MGM as a Large‐Scale Pretrained Foundation Model for Microbiome Analyses in Diverse Contexts
We present the Microbial General Model (MGM), a transformer‐based foundation model pretrained on over 260,000 microbiome samples. MGM learns contextualized microbial representations via self‐supervised language modeling, enabling robust transfer learning, cross‐regional generalization, keystone taxa discovery, and prompt‐guided generation of realistic,
Haohong Zhang +5 more
wiley +1 more source
Changes in Plasma TPH2, GDNF, Trk-b, BDNF, and proBDNF in People Who Died by Suicide
Recent studies have shown that neuropeptides and neurotrophic factors may be involved in the pathophysiological mechanisms of suicide. However, the current research on this aspect is still insufficient.
Xiaoyu Liu +4 more
doaj +1 more source
Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach [PDF]
Background: TRK fusion cancer results from gene fusions involving NTRK1, NTRK2 or NTRK3. Larotrectinib, the first selective TRK inhibitor, has demonstrated an overall response rate (ORR) of 75% with a favorable safety profile in the first 55 ...
Albert, C. M. +19 more
core +1 more source
N=2 Instanton Effective Action in Omega-background and D3/D(-1)-brane System in R-R Background
We study the relation between the ADHM construction of instantons in the Omega-background and the fractional D3/D(-1)-branes at the orbifold singularity of C \times C^2/Z_2 in Ramond-Ramond (R-R) 3-form field strength background.
A Iqbal +43 more
core +1 more source
Performance Improvements for the ATLAS Detector Simulation Framework [PDF]
Many physics and performance studies carried out with the ATLAS detector at the Long Hadron Collider (LHC) require very large event samples. A detailed simulation for the detector, however, requires a great amount of CPU resources.
Almalioglu Yasin +2 more
core +1 more source
Introduction: Pan-TRK immunohistochemistry staining can assess the protein expression from NTRK gene fusions. A little is known about its utility in differentiated thyroid cancer samples from children, adolescents, and young adults patients.
Ana Clara Oliveira Tosta Telles +11 more
doaj +1 more source
Generalizing Lieb's Concavity Theorem via Operator Interpolation [PDF]
We introduce the notion of $k$-trace and use interpolation of operators to prove the joint concavity of the function $(A,B)\mapsto\text{Tr}_k\big[(B^\frac{qs}{2}K^*A^{ps}KB^\frac{qs}{2})^{\frac{1}{s}}\big]^\frac{1}{k}$, which generalizes Lieb's concavity
Huang, De
core +1 more source

